Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.44 is 43% above its 1-year average of 1.00, near the high end of its 1-year range (0.00–1.44).
As of the fiscal period ended Tuesday, June 30, 2026. 14.27% above its 12-month average of 1.26.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.44.
CURRENT RATIO
1.44
CURRENT RATIO AVG TTM
1.26
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+14.27%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 792 covered companies
CURRENT VS SECTOR MEDIAN
-60.01%
vs the sector median at left
Lumexa Imaging Holdings, Inc. Common Stock
Market Cap
$1.03B
Current Ratio
1.44
TTM Avg
1.26
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03B
Current Ratio
6.04
TTM Avg
6.28
3Y Avg
6.71
5Y Avg
10.27
Market Cap
$1.03B
Current Ratio
16.35
TTM Avg
49.13
3Y Avg
36.30
5Y Avg
29.95
Market Cap
$1.04B
Current Ratio
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
Market Cap
$1.04B
Current Ratio
3.40
TTM Avg
1.85
3Y Avg
2.70
5Y Avg
2.88
Market Cap
$991.81M
Current Ratio
6.55
TTM Avg
7.96
3Y Avg
7.82
5Y Avg
9.82
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.03B | 1.44 | 1.26 | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.03B | 7.54 | 10.49 | 6.85 | 5.34 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.03B | 6.04 | 6.28 | 6.71 | 10.27 |
| Janux Therapeutics, Inc. (JANX)vs › | $1.03B | 16.35 | 49.13 | 36.30 | 29.95 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.04B | 8.42 | 11.89 | 15.48 | 17.00 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | 3.40 | 1.85 | 2.70 | 2.88 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | 0.83 | 2.23 | 2.80 | 3.02 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $991.81M | 6.55 | 7.96 | 7.82 | 9.82 |
| Pacira BioSciences, Inc. (PCRX)vs › | $982.98M | 5.04 | 3.47 | 3.89 | 3.30 |
Current Ratio
1.44
Quick Ratio
1.44
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.44 |
| 2026-03-31 | 1.40 |
| 2025-12-31 | 1.27 |
| 2025-09-30 | 0.92 |
| 2025-03-31 | 0.00 |
| 2024-12-31 | 0.99 |
